No significant differences in the production of IL-17 were observed between Active-TB patients, TB-treated patients or Healthy Donors, even though the patients after clinical cure seemed to tend to have lower levels than the healthy control patients in both cultures (Fig. 4E and 4F). This evidence concerns the gene IL17A and tuberculosis.